Cardinal Health (CAH) – StreetInsider.com Reports
-
Cardinal Health (CAH) Appoints Robert "Bob" Azelby to its Board
-
Leerink Partners Starts Cardinal Health (CAH) at Outperform
-
FTC Probing Shortages Of Chemotherapies, Other Drugs - WSJ
-
Argus Upgrades Cardinal Health (CAH) to Buy, 'Benefiting from its COVID-19 vaccine distribution'
-
Cardinal Health (CAH) Declares $0.5006 Quarterly Dividend; 1.9% Yield
-
Cardinal Health (CAH) PT Raised to $110 at Jefferies
-
Cardinal Health (CAH) PT Raised to $125 at UBS
-
Cardinal Health (CAH) PT Raised to $109 at TD Cowen
-
Cardinal Health (CAH) PT Raised to $133 at Baird
-
Cardinal Health (CAH) PT Raised to $115 at BofA Securities
-
Cardinal Health (CAH) PT Raised to $110 at Evercore ISI
-
Cardinal Health (CAH) Tops Q2 EPS by 23c, Beats on Revenue; Offers Upbeat FY24 EPS Guidance
-
Cardinal Health (CAH) to acquire Specialty Networks and its PPS Analytics platform for $1.2B Cash
-
Cardinal Health (CAH) PT Raised to $122 at UBS
-
Cardinal Health (CAH) PT Raised to $111 at Citi
-
Cardinal Health (CAH) PT Raised to $117 at JPMorgan
-
Cardinal Health (CAH) PT Raised to $128 at Baird
-
Midday movers: Boeing, CrowdStrike and more
-
Cardinal Health (CAH) Reports Progress on Business and Portfolio Review, Issues 2024 Guidance
-
Barclays Starts Cardinal Health (CAH) at Overweight
-
Cardinal Health (CAH) shares tumble after Wells Fargo warns of Optum concerns
-
Wells Fargo Starts Cardinal Health (CAH) at Underweight
-
Cardinal Health (CAH) PT Raised to $112 at JPMorgan
-
Cardinal Health (CAH) Declares $0.5006 Quarterly Dividend; 1.9% Yield
-
Cardinal Health (CAH) PT Raised to $105 at Jefferies
-
Cardinal Health (CAH) PT Raised to $105 at Deutsche Bank
-
Cardinal Health (CAH) PT Raised to $108 at Morgan Stanley
-
Cardinal Health (CAH) PT Raised to $114 at UBS
-
Cardinal Health (CAH) PT Raised to $108 at Citi
-
Cardinal Health (CAH) PT Raised to $126 at Baird
-
Cardinal Health (CAH) PT Raised to $104 at Mizuho Securities
-
Cardinal Health (CAH) shares climb as profits boosted by pharmaceutical and medical units
-
Cardinal Health (CAH) Tops Q1 EPS by 32c; Raises Outlook
-
Cardinal Health (CAH) PT Raised to $109 at Baird
-
Cardinal Health (CAH) PT Raised to $90 at TD Cowen
-
Cardinal Health (CAH) PT Raised to $101 at JPMorgan
-
Cardinal Health (CAH) PT Raised to $108 at Baird
-
Cardinal Health (CAH) PT Raised to $100 at Morgan Stanley
-
Cardinal Health (CAH) PT Raised to $95 at Mizuho Securities
-
Cardinal Health (CAH) tops earnings estimates, raises guidance on 'strong momentum'
-
Cardinal Health (CAH) Tops Q4 EPS by 6c, Offers Guidance
-
Cardinal Health (CAH) Declares $0.5006 Quarterly Dividend; 2.2% Yield
-
Cardinal Health (CAH) PT Raised to $107 at UBS
-
CFRA Upgrades Cardinal Health (CAH) to Sell
-
Cardinal Health (CAH) PT Raised to $94 at Mizuho Securities
-
Evercore ISI Downgrades Cardinal Health (CAH) to In Line on Valuation
-
Cardinal Health (CAH) PT Raised to $107 at Baird
-
Cardinal Health (CAH) option IV at low end of range
-
Sotera Health (SHC) Announces Jon Lyons as New Senior Vice President and Chief Financial Officer
-
Navidea Biopharma (NAVB) Receives $7.5M Cash from Cardinal Health (CAH) in Lieu of Contingent Milestone Payment
Back to CAH Stock Lookup